Clinical data registries are commonly used worldwide and are implemented for a variety of purposes ranging from physician or facility clinic logs for tracking patients, to collecting outcomes data, to measuring quality improvement or safety of medical devices. In the United States, the U.S. Food and Drug Administration has used data collected through registries to facilitate the drug and device regulatory process, for ongoing surveillance during the product life cycle, and for disease appraisals. Furthermore, the Centers for Medicare and Medicaid Services, in certain instances, bases registry participation and submitting data to registries as factors for reimbursement decisions. The purpose of this article is to discuss the use of clinical data registries; the role that medical specialty societies, in particular, the American Society of Plastic Surgeons and The Plastic Surgery Foundation, can have in the development and management of registries; and the opportunities for registry use in plastic surgery. As outcomes data are becoming essential measures of quality health care delivery, participation in registry development and centralized data collection has become a critical task for plastic surgery to engage in to proactively participate in the national quality and performance measurement agenda.
Arlington Heights and Springfield, Ill.; and Ann Arbor, Mich.
From the American Society of Plastic Surgeons; the Department of Surgery, Southern Illinois University; The Plastic Surgery Foundation; and the Section of Plastic Surgery, Department of Surgery, University of Michigan Health System.
Received for publication December 21, 2012; accepted January 15, 2013.
Disclosure: The authors have no financial interest to declare in relation to the content of this article.
Kevin C. Chung, M.D., M.S., The Plastic Surgery Foundation, 444 East Algonquin Road, Arlington Heights, Ill. 60005, firstname.lastname@example.org